Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-24

Clinical Trial Update: Feasibility Study: Ulthera System for the Treatment of Rosacea [NA]

View source ↗

Summary

This clinical trial update announces the completion of a feasibility study evaluating the Ulthera System for the treatment of erythematotelangiectatic rosacea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ulthera System

Snippet

Sponsor: Ulthera, Inc | Conditions: Erythematotelangiectatic Rosacea | NA | Status: COMPLETED